CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
about
Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanismCRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndromeBehavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Molecular pharmacology of the secretin receptorSexual dimorphism in locus coeruleus dendritic morphology: a structural basis for sex differences in emotional arousalStress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.Endogenous Opioids: The Downside of Opposing Stress.Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsRole of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptorProgress in corticotropin-releasing factor-1 antagonist development.Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitizationEffect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fearCRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cuesCorticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters.Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbensRole of corticotropin releasing factor in anxiety disorders: a translational research perspectiveAnxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Synthesis, molecular modeling and biological activity of methyl and thiomethyl substituted pyrimidines as corticotropin releasing hormone type 1 antagonists.Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects.Drugs in development for social anxiety disorder: more to social anxiety than meets the SSRI.CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.Therapeutic potential of CRF receptor antagonists: a gut-brain perspective.Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.Prevention of alcohol-heightened aggression by CRF-R1 antagonists in mice: critical role for DRN-PFC serotonin pathwayThe newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.Species and sex differences in brain distribution of corticotropin-releasing factor receptor subtypes 1 and 2 in monogamous and promiscuous vole species.Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future.Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptorsChemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.The emerging role of peripheral corticotropin-releasing hormone (CRH).Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo
P2860
Q24645551-08655311-D6C1-4D13-B83D-93EA4243F934Q24671910-23237F25-3A0F-4B0C-AD90-5E14AE5BB58CQ27014879-84F9EE21-BF4B-4DD2-8804-D09C10923450Q28203284-74735B81-D575-4251-B9D3-51D26B4F62E6Q28578768-1DD0D4C4-BA38-4747-AE7F-CFC2A170619EQ30366964-938150EE-7D99-4DDD-AF42-FD94BD6B0079Q30389951-2A8B2A12-8D5D-4B27-8ADC-BAB5FC2CA85DQ30394985-5BB83860-3BDE-4FCD-B533-5FC7BB2CE217Q30457677-003A42A5-2A22-4295-B653-111EDE5E916BQ30459612-57E69751-AD85-4D04-AE24-0C24D683E2FBQ30461988-3819A46B-099C-4F45-8185-D1055F2646EFQ30465636-6C3ECC8A-6419-4D05-B69B-74B1E2813D11Q30466695-784BA7DD-6C15-49F7-8738-D81C80C79F51Q30468942-0EA53700-51CB-4CF4-B0B7-335692322356Q30470071-D0654B10-0F46-4A0B-89C7-7E02FB12D2CCQ30475627-55B902EC-0722-4E84-B67F-519EA678CAE5Q30477874-C9B85578-5C67-4EC6-A4D9-E7B0F9F28A2FQ30477987-1865203F-2E5B-4B8F-8B54-BAF8AFE9B750Q30480573-FC6F6184-ACA5-481B-8D8C-85AA4BA48477Q30488089-302C1F23-6D2F-4A82-B8BE-FFF61C13ECCCQ30491755-C0BAC37D-CCE8-4F98-A044-A9F9A13544DFQ30498732-D7FB34BF-3823-4BAE-A7C9-C531B47BA603Q30499863-8905ED4E-25CE-4B22-AD88-3E12D08CB035Q30502566-E43304C4-2160-4521-A80C-2155A3F1FDADQ30745494-915B091A-6F8D-498B-A130-945D7EFED49FQ33577261-7201CBFB-6B8A-454C-8500-D9DD7C51C1BAQ33692610-9D6659E9-0CF1-4E47-9483-A014139A3120Q34075089-52A0D22E-603D-41B4-A88E-75C61782B6B0Q34082581-B79DF399-6F19-47F1-B997-62CA9EABEBC2Q34204338-4024B725-5591-4614-A208-667A5E344604Q34348095-4EBCE455-2924-489D-9C59-7B86B9ABA8D8Q34357024-E947CF12-0D74-447E-8B3C-89ECCC194CE9Q34989237-768FFDFE-7D38-4EE9-A3D8-2373258B4699Q35029287-F8AB652D-09D5-4B2A-AB5F-F51C65FABFE6Q35040802-F1573097-AFFA-4DC8-BF0E-8BA59DC51838Q35043823-5240048B-42C1-4607-982D-E94C2CAF1CE8Q35148867-0E28F162-C6E9-4794-AB80-0675DD4CFA0AQ35169324-9DDFE4BD-D54C-4B88-83C1-41C2FE74CD25Q35225923-4E80BA27-9F46-40E7-98DD-E30869EAE3E2Q35376083-E097F637-CC43-4E8D-89C5-BB77E161874E
P2860
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
CP-154,526: a potent and selec ...... pin releasing factor receptors
@nl
CP-154,526: a potent and selec ...... in releasing factor receptors.
@ast
CP-154,526: a potent and selec ...... in releasing factor receptors.
@en
type
label
CP-154,526: a potent and selec ...... pin releasing factor receptors
@nl
CP-154,526: a potent and selec ...... in releasing factor receptors.
@ast
CP-154,526: a potent and selec ...... in releasing factor receptors.
@en
prefLabel
CP-154,526: a potent and selec ...... pin releasing factor receptors
@nl
CP-154,526: a potent and selec ...... in releasing factor receptors.
@ast
CP-154,526: a potent and selec ...... in releasing factor receptors.
@en
P2093
P2860
P356
P1476
CP-154,526: a potent and selec ...... pin releasing factor receptors
@en
P2093
A Dunaiskis
A W Schmidt
D W Schulz
E N Winston
F D Tingley
J P Braselton
P2860
P304
10477-10482
P356
10.1073/PNAS.93.19.10477
P407
P577
1996-09-01T00:00:00Z